BLRX - BioLineRx Ltd. (BLRX) CEO Philip Serlin on Q1 2022 Results - Earnings Call Transcript
BioLineRx Ltd. (BLRX) Q1 2022 Earnings Conference Call May 11, 2022, 10:00 AM ET Company Participants Tim McCarthy - LifeSci Advisors, IR Philip Serlin - CEO Mali Zeevi - CFO Conference Call Participants Mark Breidenbach - Oppenheimer John Vandermosten - Zacks Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2022 Conference Call. All participants are presently in a listen-only mode. Following management's formal presentation instructions will be given for the question-and-answer session. [Operator Instructions] I would now like to turn the call over to Tim McCarthy of LifeSci Advisors. Please go ahead. Tim McCarthy Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements in this conference call, other than historical facts, are indeed forward-looking statements. The words anticipate, believe, estimate, expect, intend, guidance, confidence, target, project and other
For further details see:
BioLineRx Ltd. (BLRX) CEO Philip Serlin on Q1 2022 Results - Earnings Call Transcript